ArticleBriefings in bioinformatics2026
SigRescueR: a pan-system framework for noise correction and mutational signature identification across sequencing platforms.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
introductionMutational signatures serve as molecular fingerprints of the biological processes and exposures that shape cancer genomes. However, accurate signal recovery remains challenging due to pervasive background variants, sequencing artifacts, technical noise, and platform-specific biases that obscure true mutagenic patterns, hampering biomarker discovery, and mechanistic interpretation.
methodsHere we introduce SigRescueR, a rigorous, pan-system, computational framework based on Bayesian inference designed for noise correction and mutational signature identification. SigRescueR applies statistically robust baseline correction to effectively disentangle true mutational signals from confounding noise and artifacts.
resultsWhen applied to extensive datasets spanning experimental models and human cancers, SigRescueR reliably identified canonical mutational signatures associated with environmental mutagens such as colibactin, benzo[a]pyrene, and UV radiation, and chemotherapeutic agents, namely 5-fluorouracil and cisplatin. SigRescueR effectively operated across diverse mutation classes, including single base substitutions, insertions and deletions, and doublet base substitutions, while also integrating strand bias and duplex sequencing data for toxicology applications.
conclusionSigRescueR offers a unified, high-precision platform that seamlessly integrates cancer genomics, molecular toxicology, and mechanistic studies. It enables precise mapping of mutagenic processes and identification of robust genomic biomarkers of environmental and therapeutic exposures, providing a transformative framework for translational cancer research. AVAILABILITY AND IMPLEMENTATION: SigRescueR is implemented in R and provided as open-source software on GitHub at https://github.com/ZhivaguiLab/SigRescueR/.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.